Skip to main content

Scheduled maintenance

Location search will not be available from Sunday, April 12 at 9:00 PM EDT until Sunday, April 12 at 11:00 PM EDT due to planned site maintenance. We apologize for any inconvenience.

Hide
Quest Diagnostics

Lower Indeterminate Rates Using Single Lithium-Heparin Tube Blood Collection for the QuantiFERON®-TB Gold Plus (QFT®-Plus) Test

IDWeek 2020
Virtual [in-person conference canceled], October 21-25, 2020

Lower indeterminate rates using single lithium-heparin tube blood collection for the QuantiFERON®-TB Gold Plus (QFT®-Plus) test

Authors: Clark RB, Master R, Kapoor H, Kroll MH, Bi C, Salm AE, Meyer WA III

Specialties: infectious disease

Download key summary

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.